Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Technology
E-089-2002
Patent ID
E-089-2002-1-US-48
Country
US
Application Type
REISSUE
Patent Status
Expired
Patent Number
46641
Publication Number
 
Application Number
13/896,388
IC
NIAID
Date Filed
Date Issued
Patent PDF
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/46641
Related Technologies
TAB-671     Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4